LIN Linde PLC

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES                                                                                   
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940                       

1. Name and Address of Reporting Person * ANGEL STEPHEN F	2. Issuer Name and Ticker or Trading Symbol LINDE PLC [ LIN ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director                    _____ 10% Owner __X__ Officer (give title below)    _____ Other (specify below) Chief Executive Officer
(Last)          (First)          (Middle) C/O LINDE PLC, THE PRIESTLEY CENTRE, 10 PRIESTLEY ROAD	3. Date of Earliest Transaction (MM/DD/YYYY) 10/15/2019
(Street) GUILDFORD, SURREY, X0 GU2 7XY (City)        (State)        (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares								2268	I	In trust for children
Ordinary Shares								71029	I	Angel Descendants Trust
Ordinary Shares								20517	I	2012 Descendants Trust
Ordinary Shares								10570.79	I	401(k)
Ordinary Shares								194952	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0 (1)							(1)	(1)	Ordinary Shares	15755		15755	D
Restricted Stock Units	$0 (2)							(2)	(2)	Ordinary Shares	38270		38270	D
Restricted Stock Units	$0 (3)							(3)	(3)	Ordinary Shares	29580		29580	D
Restricted Stock Units	$0 (4)							(4)	(4)	Ordinary Shares	47632		47632	D
Restricted Stock Units	$0 (3)							(3)	(3)	Ordinary Shares	30215		30215	D
Restricted Stock Units	$0 (4)							(4)	(4)	Ordinary Shares	32580		32580	D
Stock Option (right to buy)	$110.58							(5)	2/26/2023	Ordinary Shares	187015		187015	D
Stock Option (right to buy)	$128.80							(5)	2/25/2024	Ordinary Shares	203930		203930	D
Stock Option (right to buy)	$128.38							(5)	2/24/2025	Ordinary Shares	261075		261075	D
Stock Option (right to buy)	$102.22							(6)	2/23/2026	Ordinary Shares	416355		416355	D
Stock Option (right to buy)	$118.71							(7)	2/28/2027	Ordinary Shares	435850		435850	D
Stock Option (right to buy)	$154.00							(8)	2/27/2028	Ordinary Shares	318780		318780	D
Stock Option (right to buy)	$176.63							(9)	3/20/2029	Ordinary Shares	177605		177605	D
Deferred Stock Units	$0 (10)	10/15/2019		A		290.245		(11)	(11)	Ordinary Shares	290.245	$0	105911.431	D

Explanation of Responses:
(1)	Restricted Stock Units that will vest in full and payout on March 20, 2022 in Linde plc Ordinary Shares on a one-for-one basis.
(2)	Restricted Stock Units that will vest in full and payout on February 27, 2021 in Linde plc Ordinary Shares on a one-for-one basis.
(3)	Restricted Stock Units that have vested in full but whose payout has been deferred to a future date.
(4)	Restricted Stock Units that will vest in full and payout on February 28, 2020 in Linde plc Ordinary Shares on a one-for-one basis.
(5)	This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant.
(6)	This option vests over three years in three consecutive equal annual installments beginning February 23, 2017.
(7)	This option vests over three years in three consecutive equal annual installments beginning on February 28, 2018.
(8)	This option vests over three years in three consecutive equal annual installments beginning on February 27, 2019.
(9)	This option vests over three years in three consecutive equal annual installments beginning on March 20, 2020.
(10)	Conversion to Linde plc Ordinary Shares is on a 1-for-1 basis.
(11)	Deferred Stock Units acquired under the Compensation Deferral Plan ("Deferral Plan") pursuant to a prior election to defer compensation. The deferred stock units will payout in Linde plc Ordinary Shares on a one-for-one basis in accordance with the Deferral Plan.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
ANGEL STEPHEN F C/O LINDE PLC THE PRIESTLEY CENTRE, 10 PRIESTLEY ROAD GUILDFORD, SURREY, X0 GU2 7XY	X		Chief Executive Officer

Signatures
Anthony M. Pepper, Attorney-in-Fact		10/17/2019
**Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} Share on Facebook Share on Twitter Share on Email